X

Vous n'êtes pas connecté

Maroc Maroc - DESANG.NET - A la Une - 11/Nov 08:35

FDA clears one-year CGM

Senseonics and its commercial partner Ascensia Diabetes Care have received clearance from the Food and Drug Administration for the first implantable glucose sensor that can be worn for one year, doubling the wear time of Senseonics’ current sensor. The continuous glucose monitor (CGM), called Eversense 365, is implanted just under the skin. A removable transmitter […]

Articles similaires

Sorry! Image not available at this time

Beta Bionics and FSL3+

desang.net - 07/Nov 11:00

Beta Bionics has announced that it has partnered with Abbott (NYSE:ABT) to integrate the company’s CGM with its automated insulin delivery system....

Sorry! Image not available at this time

HuidaGene Therapeutics gets US FDA clearance for CRISPR/Cas13 RNA─editing HG202 for macular degeneration

pharmabiz.com - 05/Nov 04:23

HuidaGene Therapeutics (HuidaGene), a global clinical─stage biotechnology company developing genome medicines, announced that the US FDA has cleared...

Biocurious: No sweat as Botanix tackles the world’s third-biggest skin disorder

stockhead.com.au - 12/Nov 19:00

Botanix's FDA-approved drug Sofdra is the first for the common and embarrassing condition of excessive sweating. ...

Sorry! Image not available at this time

Study finds big cause of rising diabetes rates in the U.S.

knowridge.com - 09/Nov 16:01

The number of American adults with diabetes is growing rapidly, with nearly 16%—or about one in six adults—now affected, according to the latest...

Sorry! Image not available at this time

CERo Therapeutics, Inc. Receives FDA Clearance of Investigational New Drug Application to Initiate Phase 1 Clinical Trial of Its Lead Compound CER-1236 in Acute Myelogenous Leukemia

mangaloremirror.com - 13:53

SOUTH SAN FRANCISCO, Calif, Nov. 15, 2024 (GLOBE NEWSWIRE) —  CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo”), an innovative...

Sorry! Image not available at this time

FDA Proposes Ban on a 'Useless' Decongestant, Phenylephrine

drugs.com - 07/Nov 16:11

THURSDAY, Nov. 7, 2024 -- More than a year after its advisory panel unanimously declared the drug phenylephrine to be useless against nasal...